Clinton Health Access Initiative (CHAI), New Delhi, India.
Johnson & Johnson Global Public Health R&D, Beerse, Belgium.
Front Public Health. 2022 May 11;10:835055. doi: 10.3389/fpubh.2022.835055. eCollection 2022.
The National TB Elimination Programme (NTEP) has quite successfully involved private sector for referral of presumptive drug resistant TB (DR-TB) patients for molecular testing and referral for DR-TB management. There was a challenge as all the referred patients were not reaching to the facilities. A "DOST" intervention model was implemented to strengthen the patient care pathway. We conducted this study to describe the patient care cascade, the clinico-demographic characteristics of patients linked to the treatment and to estimate the mean turn-around time for drug resistant TB care services.
It is a cross-sectional study conducted at New Delhi during the period July 2019-December 2020 under programmatic settings.
A total of 9,331 patients were subjected to CB-NAAT test and 382 (4%) were found to be resistant for rifampicin and 231 (76%) were initiated on treatment in the public sector under NTEP.
The DOST intervention model developed to link the DR-TB patients from private sector to the public sector DR-TB centers is found to be efficient and effective.
国家结核病消除规划（NTEP）非常成功地让私营部门参与转诊疑似耐药结核病（DR-TB）患者进行分子检测，并转诊进行 DR-TB 管理。然而，所有转诊的患者都未能到达指定机构，这构成了一个挑战。为了加强患者的护理路径，我们实施了“DOST”干预模式。我们进行这项研究是为了描述患者护理的级联情况，以及与治疗相关的患者的临床和人口统计学特征，并估计耐药结核病护理服务的平均周转时间。
这是一项在新德里进行的横断面研究，时间为 2019 年 7 月至 2020 年 12 月，在项目环境下进行。
共有 9331 名患者接受了 CB-NAAT 检测，其中 382 名（4%）对利福平耐药，231 名（76%）在 NTEP 下的公共部门开始接受治疗。
为了将私营部门的 DR-TB 患者与公共部门的 DR-TB 中心联系起来，我们开发的 DOST 干预模式被证明是有效和高效的。
